Published in Clin Pharmacol Ther on April 01, 2004
Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Clin Pharmacol Ther (2003) 1.51
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet (2010) 3.36
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. J Infect Dis (2006) 2.72
Antiviral drug-induced nephrotoxicity. Am J Kidney Dis (2005) 1.87
Antiretroviral and immunosuppressive drug-drug interactions: an update. Kidney Int (2004) 1.74
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer (2007) 1.73
Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem (2007) 1.72
Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells. Circ Res (2012) 1.68
Vaccination and chronic kidney disease. Nephrol Dial Transplant (2007) 1.63
Thrombotic microangiopathy and anti-VEGF agents. Nephrol Dial Transplant (2006) 1.61
Ear and kidney syndromes: molecular versus clinical approach. Kidney Int (2004) 1.59
Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART era. Nephron Physiol (2006) 1.51
Renal safety of tenofovir in HIV treatment-experienced patients. AIDS (2004) 1.50
Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension. Am J Kidney Dis (2007) 1.49
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrol Dial Transplant (2005) 1.49
Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation (2002) 1.47
Thrombocytopenia induced by nicotinamide in hemodialysis patients. Kidney Int (2005) 1.44
L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial. Clin J Am Soc Nephrol (2012) 1.44
International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer (2007) 1.44
Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int (2004) 1.43
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol (2008) 1.43
Lamivudine and HBV-associated nephropathy. Nephrol Dial Transplant (2005) 1.40
Once-weekly erythropoietic therapy: is there a difference between the available preparations? Nephrol Dial Transplant (2003) 1.40
Drug-induced Fanconi's syndrome. Am J Kidney Dis (2003) 1.38
Hypertension and proteinuria: a class-effect of antiangiogenic therapies. Anticancer Drugs (2009) 1.26
Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis (2008) 1.25
Is serum cystatin-C a reliable marker for metabolic syndrome? Am J Med (2008) 1.24
Plasticity of surface structures and β(2)-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure. Circ Heart Fail (2012) 1.23
Renal tubular drug transporters. Nephron Physiol (2006) 1.20
Primary chronic interstitial nephritis in Crohn's disease. Gastroenterology (2002) 1.19
Herbs and the kidney. Am J Kidney Dis (2004) 1.16
Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. Stem Cells Transl Med (2013) 1.13
Cardiomyopathy related to antimalarial therapy with illustrative case report. Cardiology (2006) 1.08
Gemcitabine-induced thrombotic microangiopathy: a systematic review. Nephrol Dial Transplant (2006) 1.08
Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword? J Am Soc Nephrol (2013) 1.07
Abnormal blood pressure circadian rhythm: a target organ damage? Int J Cardiol (2006) 1.06
Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature. Clin Pharmacol Ther (2002) 1.06
Acute Tubular Necrosis and Interstitial Nephritis during Pemetrexed Therapy. Case Rep Oncol (2009) 1.04
Post-colonoscopy appendicitis: case report and review of the literature. Am J Gastroenterol (2005) 1.04
Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study. Eur J Radiol (2009) 1.03
Post-transplantation proteinuria and sirolimus. N Engl J Med (2005) 1.03
Importance of monitoring renal function in patients with cancer. Cancer Treat Rev (2011) 1.02
Atazanavir crystal nephropathy. AIDS (2007) 1.02
Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patient. AIDS (2009) 1.01
Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study. J Am Soc Nephrol (2002) 1.01
Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. Med Sci Monit (2004) 1.00
A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination. Pharmacogenet Genomics (2005) 0.99
Renal tubular transporters and antiviral drugs: an update. AIDS (2005) 0.99
Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency. Radiology (2009) 0.98
Lung cancer and renal insufficiency: prevalence and anticancer drug issues. Lung (2008) 0.98
Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality. Clin J Am Soc Nephrol (2009) 0.97
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues. Breast Cancer Res Treat (2008) 0.97
Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters. Annu Rev Pharmacol Toxicol (2012) 0.97
Viral load and HIV-associated nephropathy. N Engl J Med (2005) 0.96
Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome? J Natl Cancer Inst (2007) 0.96
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe study. Eur J Cancer (2011) 0.96
Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study. Nephrol Dial Transplant (2011) 0.95
Kidney diseases in HIV/HCV-co-infected patients. AIDS (2009) 0.95
Sunitinib malate. Cancer Chemother Pharmacol (2006) 0.92
Outcome and prognosis factors in HIV-infected hemodialysis patients. Clin J Am Soc Nephrol (2006) 0.92
Tubulointerstitial nephritis and uveitis syndrome (TINU): a step forward to understanding an elusive oculorenal syndrome. Nephrol Dial Transplant (2008) 0.92
Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence? AIDS (2010) 0.91
Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients. Cancer (2014) 0.91
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study. Liver Int (2014) 0.90
Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin. Blood Purif (2010) 0.90
Retroperitoneal fibrosis due to Wegener's granulomatosis: a misdiagnosis as tuberculosis. Am J Med (2002) 0.90
Drug management of prostate cancer: prevalence and consequences of renal insufficiency. Clin Genitourin Cancer (2009) 0.88
Eye and kidney: from clinical findings to genetic explanations. J Am Soc Nephrol (2003) 0.88
Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinoma. Urol Oncol (2009) 0.88
From theoretical synergy to clinical supra-additive toxicity. J Clin Oncol (2009) 0.88
Fanconi syndrome associated with didanosine therapy. AIDS (2005) 0.88
Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure. Nephrol Dial Transplant (2006) 0.88